Industry News
Senz recruits first patient for leukaemia trial
Senz Oncology has recruited the first subject for the debut human trial of oral chemotherapeutic candidate VAL-1000 in patients with acute leukaemia. [ + ]
Predicting cancer: it’s all in the numbers
Australian researchers have developed a statistical model that will help identify people with a high risk of bowel and endometrial cancer. [ + ]
Biota reaps $4.2m from R&D Tax Incentive
Biota (ASX:BTA) will add a $4.2m tax credit for the December quarter to its bottom line after receiving the funds through the R&D Tax Incentive. [ + ]
Major award for global climate change scientist
The ability of a world-renowned ocean scientist to inform the media and the wider community about his work has won him a prestigious international award. [ + ]
Bioniche partner pulls plug on Urocidin trial
Bioniche (ASX:BNC) said its licensing partner has called off a phase III trial of Urocidin, a bladder cancer treatment, due in part to slow recruitment. [ + ]
CSL trials new heart attack treatment
Data from early studies of CSL's (ASX:CSL) lipoprotein-based treatment candidate show its potential in reducing the risk of recurrent heart attacks. [ + ]
Australian colorectal cancer blood test attracts attention from US
Quest Diagnostics is evaluating using a biomarker-based blood test for colorectal cancer developed by Clinical Genomics, the CSIRO and the Flinders Centre for Innovation in Cancer. [ + ]
Monash team wins grant for inhalable oxytocin
A Monash University team has won a $1 million grant to develop an inhalable oxytocin treatment for post-partum haemorrhage, a leading cause of death in emerging markets. [ + ]
Sea snails could have medicinal purposes
A workshop for the development of natural medicines from the Muricidae family of sea snail will be conducted at Southern Cross University (SCU) this week. [ + ]
Comment: How we developed the Hendra virus vaccine for horses
Deborah Middleton, Senior Veterinary Pathologist at CSIRO, explains how she and her team developed the groundbreaking vaccine for the deadly Hendra virus. [ + ]
AusBiotech appoints new board member
AusBiotech yesterday announced the election of a new member to its board of directors following the national biotechnology organisation’s annual general meeting, held at the national conference in Melbourne. [ + ]
UQ start-up wins prestigious biotechnology award
Vaxxas, a UniQuest start-up established in 2011 to commercialise the Nanopatch vaccine delivery system based on research from The University of Queensland (UQ), has won the Janssen 2012 AusBiotech Emerging Company Award. [ + ]
EMD Millipore and Sistemic collaborate to identify control markers for stem cell production
EMD Millipore and Sistemic are jointly developing a monitoring methodology utilising Sistemic’s microRNA marker detection capability to enable consistent growth of stem cells in EMD Millipore’s Mobius CellReady platform. [ + ]
Meet the Science Minister’s Prize for Life Scientist of the Year: Mark Shackleton
Cancer researcher, Professor Mark Shackleton, has been awarded the Science Minister’s Prize for Life Scientist of the Year for his work understanding the nature of cancer. [ + ]
Michelle Burke joins AusBiotech board
Pharmaceutical industry and policy expert, Michelle Burke, has joined the AusBiotech board, as Dr Paul Walton and Dr Peter Isdale AM depart. [ + ]